Sage Therapeutics Inc (SAGE)
8.21
+0.11
(+1.36%)
USD |
NASDAQ |
Mar 24, 16:00
8.10
-0.11
(-1.34%)
After-Hours: 04:42
Sage Therapeutics Enterprise Value: 0.3402M for March 24, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Biogen Inc | 24.65B |
| Moderna Inc | 6.186B |
| Johnson & Johnson | 405.62B |
| Intra-Cellular Therapies Inc | 13.00B |
| Cytokinetics Inc | 5.095B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -95.78M |
| Revenue (Quarterly) | 12.82M |
| Total Expenses (Quarterly) | 93.16M |
| EPS Diluted (Quarterly) | -1.56 |
| Gross Profit Margin (Quarterly) | 88.38% |
| Profit Margin (Quarterly) | -747.3% |
| Earnings Yield | -80.27% |
| Normalized Earnings Yield | -75.92 |